CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million
CareDx will acquire Naveris for $160 million, adding a Medicare-reimbursed liquid biopsy platform for viral-mediated cancer monitoring to its precision medicine portfolio.
Tag: HPV
All
Latest
All
Latest
Studies Showcase Less Invasive, More Equitable Testing for Women’s Cancers
At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
All
Latest
Why Self-collection Is the Means to Maximize Cervical Cancer Screening
There are significant barriers to cervical cancer screening. Sample self-collection promises to improve access to testing and treatment.
Mobile Cancer Screening Vehicle Rolled Out
The University of Florida Health Cancer Center has introduced a 40-foot mobile cancer screening bus to provide essential cancer screenings.
Read More
Women Prefer Self-Sampling Option for Cervical Cancer Screening
A new study reveals that 85% of women would welcome the option to choose between self-sampling and nurse-led HPV cervical screening.
Read More
Will HPV Self-Collection Help Prevent Cervical Cancer?
In this episode of Clinical Lab Chat, we discuss what sample self-collection means for the diagnosis and treatment of HPV and cervical cancer.
Read More
Noninvasive Urine Test Could be Key in Cervical Cancer Detection
Researchers developed a urine test using ELISA to detect HPV16 E7 oncoproteins, a noninvasive method for cervical cancer screening.
Read More
HPV Self-Collection Is Recommended by Health Care Providers
A new study highlights support among healthcare providers for HPV self-collection, which could improve access to cervical cancer screening.
Read More
Syphilis Cases are Rising, but Many Don’t Know the Symptoms
Syphilis cases are rising globally, yet many Americans remain unaware of its symptoms and treatment options.
Read More
PROphet Platform’s Predictive Ability to be Demonstrated
OncoHost will highlight the PROphet platform’s capability to predict benefits from therapies across various cancers.
Read More
Roche Announces FDA Approval of HPV Self-Collection Solution
che received FDA approval for its HPV self-collection solution, allowing individuals to collect their own samples.
Read More
Post-Viral Syndromes and the Utility of T-cell Diagnostics
There is a potential to use T-cell diagnostics to diagnose underlying post-viral syndromes by measuring the bodies adaptive immune resistance.
Read More
CMS Designates HPV Blood Test as an Advanced Diagnostic Lab Test
The TTMV-HPV DNA blood test provides a non-invasive method for detecting HPV-driven cancers before there is clinical evidence of disease.
Read More
New Initiative Aims to Advance HPV-Driven Cancer Test
Naveris Launched an initiative aimed to expand the applications of its circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test.
Read More
BD and Camtech Health Partner to Improve Cervical Cancer Screening Access in Singapore
BD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Read More
Cervical Cancer Screening: Survey Points to Self-Collection as Improving Access
In BD’s newest global survey, women reported self-collection would motivate them to have regular cervical cancer screening.
Read More
How Liquid Biopsy of Lymph Fluid Could Guide Head and Neck Cancer Treatment
Researchers discovered that lymphatic fluid from surgical drains could inform precise treatments for patients with head and neck cancer.
Read More
Moffitt Gets Grant to Evaluate Oropharyngeal Cancer Test
The $3.6 million grant aims to further research on a noninvasive diagnostic biomarker panel for the early detection of oropharyngeal cancer.
Read More